Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

This clinicaI trial is being done to determine if acupressure is helpful to reduce anxiety related to chemotherapy, compared with "sham" (or placebo) acupressure in patients with cancer. Anxiety, experienced by many patients with cancer, can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicine ways to manage symptoms. Acupressure is the application of non-invasive finger pressure along energy points throughout the body in order to relieve pain and induce a feeling of well-being. Previous research has shown that acupressure can help both adults and children with their anxiety in certain situations, such as after surgery. Patients can be taught how to do the acupressure on themselves, making this an intervention that can be done anywhere. Acupressure is well tolerated with minimal reports of adverse reactions. Undergoing acupressure may be effective in reducing anxiety in cancer patients receiving chemotherapy.

Eligibility criteria

Qualifiers

NURSE-LED INTERVENTION: Age >= 18 years and be diagnosed with cancer

NURSE-LED INTERVENTION: Undergoing systemic, antineoplastic therapy

NURSE-LED INTERVENTION: Ability to provide oral consent

NURSE-LED INTERVENTION: Willingness to undergo a nurse-led acupressure intervention

Disqualifiers

Prior experiences with acupressure, or training in acupressure points

Trial design

Treatments tested in this trial

  • Acupressure Therapy
  • Acupressure Therapy - placebo
  • Acupressure Therapy - self-administered
  • Health Promotion and Education
  • Survey Administration

Treatment groups

78 Participants
are divided into 2 treatment groups

Sponsors and collaborators